4.5 Article

Mesoporous iron oxide nanoparticles prepared by polyacrylic acid etching and their application in gene delivery to mesenchymal stem cells

期刊

MICROSCOPY RESEARCH AND TECHNIQUE
卷 76, 期 9, 页码 936-941

出版社

WILEY-BLACKWELL
DOI: 10.1002/jemt.22251

关键词

postsynthesis etching; mesoporous nanostructures; iron oxide nanoparticles; gene delivery

资金

  1. National Science Foundation [CBET-0854465, CBET-0854414, DMR-0847758]
  2. National Institutes of Health [5R01HL092526-02, 1R21EB015190-01A1, 4R03AR056848-03]
  3. Department of Defense Peer Reviewed Medical Research Program [W81XWH-12-1-0384]
  4. Oklahoma Center for the Advancement of Science and Technology [HR11-006]
  5. Oklahoma Center for Adult Stem Cell Research [434003]
  6. Direct For Mathematical & Physical Scien
  7. Division Of Materials Research [847758] Funding Source: National Science Foundation
  8. Div Of Chem, Bioeng, Env, & Transp Sys
  9. Directorate For Engineering [0854465] Funding Source: National Science Foundation
  10. Div Of Chem, Bioeng, Env, & Transp Sys
  11. Directorate For Engineering [0854414] Funding Source: National Science Foundation

向作者/读者索取更多资源

Novel monodisperse mesoporous iron oxide nanoparticles (m-IONPs) were synthesized by a postsynthesis etching approach and characterized by electron microscopy. In this approach, solid iron oxide nanoparticles (s-IONPs) were first prepared following a solvothermal method, and then etched anisotropically by polyacrylic acid to form the mesoporous nanostructures. MTT cytotoxicity assay demonstrated that the m-IONPs have good biocompatibility with mesenchymal stem cells (MSCs). Owing to their mesoporous structure and good biocompatibility, these monodisperse m-IONPs were used as a nonviral vector for the delivery of a gene of vascular endothelial growth factor (VEGF) tagged with a green fluorescence protein (GFP) into the hard-to-transfect stem cells. Successful gene delivery and transfection were verified by detecting the GFP fluorescence from MSCs using fluorescence microscopy. Our results illustrated that the m-IONPs synthesized in this work can serve as a potential nonviral carrier in gene therapy where stem cells should be first transfected and then implanted into disease sites for disease treatment. Microsc. Res. Tech. 76:936-941, 2013. (c) 2013 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据